Highly specific and ultrasensitive plasma test detects Abeta(1–42
Frontiers The Beta Amyloid Dysfunction (BAD) Hypothesis for
Biomarkers for Alzheimer's disease-preparing for a new era of
Frontiers Association Between Plasma Amyloid-β and Neuropsychological Performance in Patients With Cognitive Decline
Overview of the blood biomarkers in Alzheimer's disease: Promises
Amyloid beta (Aβ)1‐40 (top), Aβ1‐42 (middle), and Aβ1‐42/Aβ1‐40
Comparison of ultrasensitive and mass spectrometry quantification of blood-based amyloid biomarkers for Alzheimer's disease diagnosis in a memory clinic cohort
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias - ScienceDirect
Plasma a Aβ 1-40 , b Aβ 1-42 , c tau, d Aβ 1-42 /Aβ 1-40 , and e
Biosensors, Free Full-Text
Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis
PDF) Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia
Trajectories of CSF and plasma biomarkers across Alzheimer's
PDF) Highly Specific and Ultrasensitive Plasma Test Detects Abeta
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias - ScienceDirect